ConductScience.org, home

Paper658981

Factors influencing the in vitro interaction between immunoglobulins and isolated C1: a critical study.

Füst G and 4 others. Immunology, 1978. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Factors influencing the in vitro interaction between immunoglobulins and isolated C1: a critical study. Papers, record 658981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/658981

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors influencing the in vitro interaction between immunoglobulins and isolated C1: a critical study.
PubMed
Journal
Immunology
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.04
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Füst GG
2Medgyesi GAG A
3Csécsi-Nagy MM
4Rajnavölgyi EE
5Gergely JJ

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C1Major topic
ImmunoglobulinsMajor topic
Animals
Complement C4
Complement Fixation Tests
Gelatin
Hemolysis
Humans
Immunoglobulin Fragments
Rats

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114265901STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. II. RESOLUTION OF THE E TRANSFORMATION REACTION INTO MULTIPLE STEPS.J Immunol1965https://conductscience.org/library/papers/14265901PubMed
25960883Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.Immunochemistry1966https://conductscience.org/library/papers/5960883PubMed
31086286The enhancement of the haemolytic activity of the first component of complement by trasylol.Immunology1976https://conductscience.org/library/papers/1086286PubMed
44121391Binding properties of the human complement protein Clq.J Biol Chem1973https://conductscience.org/library/papers/4121391PubMed
54107360Purification of the first component of human complement by affinity chromatography on human globulin linked to sepharose.J Immunol1971https://conductscience.org/library/papers/4107360PubMed
64166243Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.J Immunol1967https://conductscience.org/library/papers/4166243PubMed
74202729Fab-related fragments of human IgG produced by partial tryptic proteolysis.Immunochemistry1973https://conductscience.org/library/papers/4202729PubMed
84477553The interactions of human complement with interfacially aggregated preparations of human secretory IgA.Immunochemistry1974https://conductscience.org/library/papers/4477553PubMed
94945437The reaction of monomeric and aggregated immunoglobulins with C1.Immunochemistry1971https://conductscience.org/library/papers/4945437PubMed
104972623The purification and reactivity of the first component of complement from guinea pig, human and canine sera.J Immunol1968https://conductscience.org/library/papers/4972623PubMed
111278389Ultracentrifugation studies on the native form of the first component of human complement (C1).FEBS Lett1976https://conductscience.org/library/papers/1278389PubMed
12938474Subunit composition and structure of subcomponent C1q of the first component of human complement.Biochem J1976https://conductscience.org/library/papers/938474PubMed
131194853C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.J Exp Med1975https://conductscience.org/library/papers/1194853PubMed
141167567Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.J Immunol1975https://conductscience.org/library/papers/1167567PubMed
155666030Enchancement by butanediamine of the reaction of the first component of complement with EAC'4.Immunochemistry1968https://conductscience.org/library/papers/5666030PubMed
165645221Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength.J Immunol1968https://conductscience.org/library/papers/5645221PubMed
1714106307EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS.J Immunol1963https://conductscience.org/library/papers/14106307PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/658981

GET https://conductscience.org/api/papers/v1/658981/authors